forecast glp-1 prescriptions growth 2025 Receptor Agonist Market Size How oral GLP-1s could reshape

N Engl J Med 384(12):11131124 Osaka T, Endo M, Yamakawa M, Inoue S (2005) Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system

Ozempic received initial FDA approval for diabetes treatment in 2017

In fact, FDA labels for these medications include warnings about acute kidney injury risk, particularly when dehydration occurs from severe gastrointestinal adverse events

Extra caution is necessary for patients on medications with narrow therapeutic windows, such as tacrolimus

For SGLT2i, no differences were observed in MACE, cardiovascular death or HHF, major kidney outcomes and mortality rates in those using vs those not using metformin [174]

For broader clinical guidance, organizations like the American Heart Association provide evidence-based recommendations on managing cardiovascular risk